'Digital Pill' Tells Doctors When Patient Takes It

The U.S. Food and Drug Administration has just approved the first drug designed to alert doctors when their patient have taken their medication.

The drug is called Albilify MyCite and it has an embedded sensor that sends a message to a patch worn by the patient. The patch then records the data to which the Doctor and patient can monitor through a smart phone.

The drug was first approved in 2012. However, the FDA just recently announced that Albilify is now "OK'd" to treat mental disorders such as schizophrenia, manic depression, and bipolar disorder.

"Being able to track ingestion of medications prescribed for mental illness may be useful for some patients," said Dr. Mitchell Mathis, director of the agency's Division of Psychiatry Products.

The drug has not, however been proven to improve patient compliance. The FDA commented that the drug should not be used to track scheduled ingestion for the data may be inaccurate and delayed.

It is quite amazing how medical advancements are changing the lives all around the world. The rapid progression of medicine and technology impacts millions of individuals and increases life expectancy.

To see more information on Albilify MyCite and to read Scott Roberts entire article please follow the link below:

https://medlineplus.gov/news/fullstory_169697.html